Johnson & Johnson announces call for nominations

February 16, 2007

New Brunswick, New Jersey - February 15, 2007 - Johnson & Johnson today announced that it will accept nominations for The 2008 Dr. Paul Janssen Award for Biomedical Research beginning on June 1, 2007. At that time, nominations will be accepted on-line via the Award website at http://www.pauljanssenaward.com and the winner will be announced in September 2008.

The Dr. Paul Janssen Award for Biomedical Research was established by Johnson & Johnson in 2004 to honor Dr. Paul Janssen, founder of Janssen Pharmaceutica. Dr. Janssen, who was known to his colleagues as Dr. Paul, was one of the most innovative, creative, and productive scientists of the 20th century. The Award is designed to acknowledge a scientist from anywhere in the world whose work has the potential to make a significant transformational contribution toward the improvement of human health. Given every two years, the Award includes a $100,000 cash prize and recipients are chosen by an independent Selection Committee composed of world-leading scientists and clinicians Solomon Snyder, M.D., D.Sc., D.Phil. (Hon. Causa), professor and director of the Department of Neuroscience at Johns Hopkins School of Medicine will chair the Selection Committee for the 2008 Award.

"I am very honored to chair the 2008 Dr. Paul Janssen Award Selection Committee," said Dr. Snyder. "I expect there will be many excellent scientists nominated for this award and selecting a winner will be a challenging process. However, we are looking forward to finding the scientist whose work and research has the potential to help millions of people while epitomizing the passion, leadership and innovation that defined Dr. Janssen."

Craig C. Mello, Ph. D., a professor of Molecular Medicine at the University of Massachusetts Medical School, Worcester, MA, and an investigator at the Howard Hughes Medical Institute, was named the inaugural recipient of the Award in September 2006 for his work in RNA interference (RNAi). Dr. Mello was later co-awarded the 2006 Nobel Prize in Physiology or Medicine for his contribution related to the discovery of to RNAi.

More information about the nomination process, as well as the 2008 Selection Committee, will become available later this spring.
-end-
About The Dr. Paul Janssen Award for Biomedical Research

The Dr. Paul Janssen Award for Biomedical Research was established by Johnson & Johnson in 2004 to honor Dr. Paul Janssen, founder of Janssen Pharmaceutica. Dr. Janssen, who was known to his colleagues as Dr. Paul, was one of the 20th century's most gifted and passionate scientists. At the time of his death in 2003, Dr. Paul had contributed to the discovery and development of more than 80 medicines that have helped save millions of lives. For more information about Dr. Paul Janssen and the Award, please go to http://www.pauljanssenaward.com.

About Johnson & Johnson

Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical and medical devices and diagnostics markets. The more than 200 Johnson & Johnson operating companies employ approximately 122,000 men and women and sell products throughout the world.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Related Biomedical Research Articles from Brightsurf:

General data protection regulation hinders global biomedical research
The European Union (EU) General Data Protection Regulation (GDPR) was designed to give EU citizens greater protection and control of their personal data, particularly when transferred to entities outside the EU.

Novel educational program puts a human face on biomedical research
The goal of translational research is to speed research breakthroughs into clinical practice.

Biomedical research may miss key information by ignoring genetic ancestry
A new study of Black residents of four distinct US cities reveals variations in genetic ancestry and social status that underscore the inadequacy of using skin color as a proxy for race in research.

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.

World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.

Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.

Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.

As private funding of biomedical research soars, new risks arise
Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.

BGRF scientists co-publish research paper on blockchain & AI for biomedical applications
Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.

Promising new drug for Hep B tested at Texas Biomedical Research Institute
Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

Read More: Biomedical Research News and Biomedical Research Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.